Navigation Links
Vyta Corp Announces Engagement of Dr. Nino Sorgente as Independent Consultant
Date:10/8/2008

DENVER, Oct. 8 /PRNewswire-FirstCall/ -- Vyta Corp (OTC Bulletin Board: VYTC) today announced that effective October 7, 2008, Dr. Nino Sorgente has been formally engaged as an independent scientific consultant to Vyta Corp. Dr. Sorgente was formerly Vice President of Research and Development at BIOAGRA, LLC, a joint venture, equally owned by Vyta Corp and Justin Holdings, Inc. On September 15, 2008, Vyta Corp announced its filing of foreclosure litigation against BIOAGRA, LLC. BIOAGRA, LLC manufactures, markets and distributes AGRASTIM(R), a proprietary all-natural, biologically active yeast Beta-1,3/1,6-D-glucan feed supplement.

"We are pleased to retain the services of Dr. Sorgente," said Paul H. Metzinger, President and CEO of Vyta Corp. "Dr. Sorgente is recognized as one of the leading Beta glucan researchers for his contributions to the cosmetic, medical and agricultural applications of Beta glucan."

About Vyta Corp

Vyta Corp, based in Denver, Colorado, is traded on the over-the-counter NASDAQ stock market (OTCBB: VYTC) as well as on the Frankfurt, Hamburg, XETRA and Munich Exchanges (OTC:VYTA).

In addition to its interest in BIOAGRA, LLC, Vyta Corp owns various patents and intellectual properties related to NCS(R) (NanoPierce Connection System) an advanced electronic connection system. For more information on Vyta Corp, please visit its website at http://www.vytacorp.com .

About BIOAGRA, LLC

BIOAGRA, LLC is based in Hinesville, Georgia, where it produces, markets and sells AGRASTIM(R), which is a purified, all natural, nontoxic yeast Beta 1,3/1,6-D-glucan product with a high bioactivity function that improves the immune systems of animals and humans. AGRASTIM(R) is also used to replace growth promotion antibiotics that are currently used in the feed of the beef and dairy cattle, equine, swine, poultry and aquaculture industries.

This announcement contains forward-looking statements about Vyta Corp that may involve risks and uncertainties. Important factors relating to the Company's operations could cause results to differ materially from those in forward-looking statements and further detailed in filings with the Securities and Exchange Commission (SEC) available at the SEC website (http://www.sec.gov). All forward-looking statements are based on information available to Vyta Corp on the date hereof and Vyta Corp assumes no obligation to update such statements.

Contacts:

Vyta Corp

Paul H. Metzinger

President & Chief Executive Officer

370 17th St.

Suite 3640

Denver, CO 80202

303-592-1010

Fax: 303-592-1054

E-mail: paul@vytacorp.com


'/>"/>
SOURCE Vyta Corp
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Disaboom Announces Preliminary Third Quarter Results
2. Medifast Announces Opening of First Franchise Clinic
3. SXC Health Solutions announces PBM certification from the HR Policy Association
4. ALL Care Dental Plan Announces Expansion to New Key States
5. ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly
6. Alfred Taubman Announces New $22M Gift to U-M
7. Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix
8. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
9. Vision Audio Inc. Announces New EASe Games Designed for Children with Autism
10. Information Management Solutions Provider OCI Announces Redesign of Corporate Web Site
11. Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 16, 2017 , ... Specialty Technical Publishers (STP) ... Audit Protocol Consortium (IAPC) EHS audit protocol for Singapore . Leading companies ... their EHS regulatory obligations and rapidly collect, share, archive, and export audit findings ...
(Date:1/16/2017)... IL (PRWEB) , ... January 16, 2017 , ... ... (iaedp) organized to provide first-quality education and high-level training standards to an international ... spectrum of eating disorder problems. As a way to further its mission at ...
(Date:1/15/2017)... New York, NY (PRWEB) , ... January 15, 2017 , ... ... growing strategic accounts in the United States for the asthma & allergy friendly mark. ... of America to independently test and identify consumer products to be more suitable for ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco Magazine recently queried ... counties for 2017. Almost 1,000 nominations were submitted and a little over 500 ... were announced the magazine’s January 2017 issue . , Under the category ...
(Date:1/14/2017)... ... January 13, 2017 , ... According to ... magnesium-rich Mediterranean diet may lower the risk of type 2 diabetes, Alzheimer’s, and ... many health and wellness benefits linked to a Mediterranean diet are only some ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... ROCKVILLE, Md. , Jan. 16, 2017 /PRNewswire/ ... tomography (CT) systems market is valued at $4.9 ... applications for CT, coupled with an aging population ... incidence of chronic disease, is propelling the market ... report, Computed Tomography Markets , focuses on ...
(Date:1/16/2017)... 2017 The report "Cellulose ... (Methyl, Ethyl, Hydroxyethyl, Hydroxypropyl, Carboxymethyl Cellulose), Application ... Coatings & Paints), Region - Global Forecast ... was valued at USD 4.51 Billion in ... 6.41 Billion by 2021, at a CAGR ...
(Date:1/16/2017)... , Jan. 16, 2017  Dovetail Genomics today ... sequencing and assembly service, which yields chromosome-scale genome assemblies. ... in a Dovetail-hosted workshop on Jan. 17 at the ... San Diego . "We are ... the launch of our Dovetail Hi-C offering," said ...
Breaking Medicine Technology: